Core Viewpoint - The company has decided not to adjust the conversion price of the Tianjian convertible bonds despite triggering the downward adjustment clause due to stock price performance [1][5]. Group 1: Convertible Bond Issuance - The company issued convertible bonds totaling 495 million yuan, with a face value of 100 yuan per bond, and the bonds were listed on September 19, 2022 [2]. - The conversion price is set at 85% of the stock price, which is 45.00 yuan per share, and the downward adjustment clause was triggered as the stock price fell below this threshold for 15 out of 30 trading days [3][4]. Group 2: Decision on Price Adjustment - The board of directors approved the decision not to adjust the conversion price during a meeting held on June 24, 2025, considering various factors including market conditions and the company's long-term potential [5]. - The company will not propose a downward adjustment for six months following the board's decision, from June 25, 2025, to December 24, 2025, but may reconsider if the adjustment clause is triggered again after December 25, 2025 [1][5].

Core Viewpoint - The announcement details the issuance and terms of the convertible bond "NanYao Convertible Bond" by Nanjing Pharmaceutical Co., Ltd, including its conversion price, issuance scale, and relevant procedures for bondholders [1][2][3]. Group 1: Issuance Overview - The convertible bond code is 110098 and the bond name is "NanYao Convertible Bond" [1]. - The total issuance amount is 1,081.49 million RMB, with each bond having a face value of 100 RMB [2]. - The bond has a term of 6 years, from December 25, 2024, to December 24, 2030 [2]. Group 2: Conversion Terms - The conversion price is set at 5.12 RMB per share [2][4]. - The conversion period starts from July 1, 2025, and ends on December 24, 2030 [2][3]. - The bond has a tiered interest rate structure, starting at 0.20% in the first year and increasing to 2.00% in the sixth year [2]. Group 3: Conversion Procedures - Bondholders can apply for conversion during the specified conversion period on trading days [3]. - The conversion process includes a mechanism for handling fractional shares and the calculation of the actual convertible bond quantity [3][4]. - Newly converted shares will have the same rights as existing shares [4]. Group 4: Adjustment of Conversion Price - The initial conversion price was set at 5.29 RMB per share, which has been adjusted to 5.12 RMB due to a cash dividend distribution [5][6]. - The conversion price can be adjusted based on various corporate actions, including stock dividends and cash dividends [6][8]. - The company has the right to propose downward adjustments to the conversion price if the stock price falls below certain thresholds [8][9]. Group 5: Redemption and Sale Rights - The company may redeem the unconverted bonds at 108% of the face value within five trading days after maturity [10]. - Bondholders have the right to sell back their bonds to the company if the stock price falls below 70% of the conversion price during the last two interest years [10][12]. - Additional sale rights are available if there are significant changes in the use of raised funds [12].

债券代码：110098 债券简称：南药转债 证券代码：600713 证券简称：南京医药 编号：ls2025-091 南京医药股份有限公司 关于因实施权益分派调整可转债转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 调整前转股价格：5.29 元/股 ? 调整后转股价格：5.12 元/股 ? "南药转债"本次转股价格调整实施日期：2025 年 6 月 30 日 限公司向不特定对象发行可转换公司债券注册的批复》（证监许可【2024】1736 号）， 核准南京医药股份有限公司（以下简称"公司"）本次可转换公司债券（以下简称"可 转债"）发行。公司向不特定对象发行可转债 10,814,910 张，每张面值为人民币 100 元，并于 2025 年 1 月 20 日在上海证券交易所上市交易（债券简称：南药转债，债券 代码：110098），初始转股价格为 5.29 元/股。 一、转股价格调整依据 公司股份回购专用证券账户持有股数）为基数分配利润，向全体股东每 10 股派发现金 红利 1.70 元（含税）。在 ...

Key Points - The company has issued convertible bonds with a total amount of 2 billion yuan, which began trading on November 16, 2020 [1] - The conversion period for the bonds is from April 22, 2021, to October 15, 2026 [2] - The conversion price has been adjusted multiple times due to profit distribution, with the latest adjustment reducing it to 10.91 yuan per share effective June 26, 2024 [3] - A recent board meeting approved a further reduction of the conversion price to 9.20 yuan per share, effective from November 2024 [4] - The company has outlined specific conditions under which the conversion price can be adjusted downward, including a scenario where the stock price falls below 85% of the current conversion price for at least 15 trading days [5] - The company is required to disclose any adjustments to the conversion price in accordance with regulatory guidelines [6]

汇通建设集团股份有限公司 关于实施 2024 年度权益分派时"汇通转债"停止转股 的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603176 证券简称：汇通集团 公告编号：2025-042 债券代码：113665 债券简称：汇通转债 重要内容提示： ?证券停复牌情况：适用 因实施 2024 年年度权益分派,本公司的相关证券停复牌情况如下： 停牌期 证券代码 证券简称 停复牌类型 停牌起始日 停牌终止日 复牌日 间 ?2024 年年度权益分派公告前一交易日（2025 年 6 月 27 日）至权益分 派股权登记日期间，公司可转换公司债券（以下简称"汇通转债" 停止转股。 一、权益分派的基本情况 公司 2024 年度利润分配方案>的议案》，决定以公司 2024 年度权益分 派股权登记日登记的总股本为基数分配利润，向登记在册的全体普通 股股东每 10 股派发现金股利 0.23 元（含税）。公司已于 2025 年 5 月 团股份有限公司 2024 年年度股东大会决议公告》 （公告编号： 本次权益分派实施后，公司 ...

Core Viewpoint - The banking sector is experiencing a strong performance, leading to an accelerated conversion of convertible bonds into stocks this year, with several banks triggering redemption clauses for their convertible bonds [2][7]. Group 1: Convertible Bond Redemption - Qilu Bank announced that its stock price has been above 130% of the current conversion price for 10 out of the last 15 trading days, which may trigger the redemption clause for its convertible bonds [4]. - If Qilu Bank's stock price remains above 6.50 CNY (130% of the adjusted conversion price of 5.00 CNY) for 5 more trading days, the bank has the right to redeem the bonds at face value plus accrued interest [4][5]. - This year, five convertible bonds from various banks have exited the market due to triggering redemption clauses, including those from Suhang Bank, Chengyin Bank, Hangyin Bank, and Nanyin Bank [8]. Group 2: Market Trends and Implications - The continuous rise in bank stock prices has led to a significant reduction in the outstanding balance of Qilu convertible bonds, which currently stands at 60.87 billion CNY, with an unconverted ratio of 76.09% [4]. - The trend of convertible bonds exiting the market is expected to continue, with only seven remaining if Qilu's bonds are redeemed [8]. - Approximately 100 billion CNY of bank convertible bonds are anticipated to complete conversion this year due to rising stock prices [8]. Group 3: Capital Supplementation and Market Dynamics - Convertible bonds serve as a crucial tool for banks to supplement their core Tier 1 capital, with a strong incentive for banks to convert bonds into stocks to enhance capital adequacy [2][11]. - The adjustment of conversion prices, such as Qilu Bank's reduction from 5.14 CNY to 5.00 CNY, increases the likelihood of triggering redemption clauses [9]. - The acceleration of bond conversions, combined with a slow pace of new bond approvals and issuances, may lead to irrational price increases for remaining high-quality convertible bonds in the market [11].

Core Viewpoint - Qilu Bank's convertible bonds may trigger redemption clauses due to the stock price remaining above 130% of the conversion price for a significant number of trading days, indicating strong market performance and potential capital strengthening for the bank [1][4][6]. Group 1: Convertible Bond Redemption - Qilu Bank announced that its stock price has been above 130% of the convertible bond's conversion price for 10 out of the last 15 trading days, which could lead to the triggering of redemption clauses if this trend continues [1][4]. - The conversion price for Qilu's bonds was adjusted from 5.14 CNY to 5.00 CNY, making the new threshold for triggering redemption 6.50 CNY [4][10]. - If the redemption clause is triggered, Qilu Bank has the right to redeem all or part of the unconverted bonds at face value plus accrued interest [5][6]. Group 2: Market Trends and Implications - This year, several bank convertible bonds have triggered strong redemption, with five bonds exiting the market, highlighting a trend of increasing bond scarcity [2][9]. - The rising stock prices of banks have led to a significant number of convertible bonds potentially triggering redemption, with estimates suggesting around 100 billion CNY in bank convertible bonds may convert this year [10][12]. - The adjustment of conversion prices by banks is aimed at increasing the likelihood of triggering redemption, thereby enhancing their capital positions [10][12].

Group 1 - The company announced an adjustment to the conversion price of its convertible bonds, changing from RMB 5.50 to RMB 5.44 per share, effective from June 30, 2025 [1][4] - The adjustment is based on the company's profit distribution plan, which was approved at the 2024 annual general meeting, involving a cash dividend of RMB 0.593337 per 10 shares [2][3] - The total number of shares for the cash dividend calculation is based on the existing total share capital of 611,892,406 shares, excluding repurchased shares [2][3] Group 2 - The company will publish announcements regarding the conversion price adjustments in accordance with relevant regulations, ensuring the protection of convertible bondholders' rights [2] - The cash dividend will be distributed to shareholders based on a record date of June 27, 2025, with the ex-dividend date set for June 30, 2025 [2][4] - The adjustment formula for the conversion price considers various scenarios such as stock dividends, capital increases, and cash dividends [1][2]

Core Viewpoint - Zhejiang Huayou Cobalt Co., Ltd. plans to change the source of shares for the "Huayou Convertible Bonds" from "newly issued shares" to "priority use of repurchased shares, with any shortfall covered by newly issued shares" [2][9] Summary by Sections Convertible Bond Issuance Overview - The company issued 76 million convertible bonds on February 24, 2022, with a total fundraising amount of 760 million yuan, netting 755.38 million yuan after expenses [2][3] - The bonds began trading on the Shanghai Stock Exchange on March 23, 2022, under the name "Huayou Convertible Bonds" with the code "113641" [3] Convertible Bond Conversion Situation - The initial conversion price was set at 110.26 yuan per share, which has been adjusted multiple times, with the latest price at 34.43 yuan per share [2][4] - The conversion period is from September 2, 2022, to February 23, 2028 [2] Confirmation of Conversion Source Change - The company has completed the necessary legal procedures to change the conversion source, allowing for the use of repurchased shares for conversion starting June 23, 2025 [9] - The company plans to repurchase shares at a price not exceeding 60 yuan per share, with a total repurchase fund of no less than 600 million yuan [8] Repurchase Share Situation - The repurchased shares will be stored in a dedicated securities account, and the total amount of repurchased shares is 750.50 million yuan [8]

Group 1 - The company issued 7,500,000 convertible bonds with a total amount of RMB 750 million, which started trading on September 8, 2021 [1][2] - The initial conversion price for the bonds was set at RMB 4.87 per share, which has undergone several adjustments due to stock price fluctuations [2][3][5] - The company has triggered conditions for a potential downward adjustment of the conversion price, as the stock price has been below 85% of the current conversion price for 10 consecutive trading days [1][8][9] Group 2 - The conversion period for the bonds is from February 14, 2022, to August 8, 2027, allowing bondholders to convert their bonds into shares during this timeframe [2] - The company has outlined specific conditions under which the conversion price can be adjusted downward, requiring approval from shareholders [8][9] - The company is obligated to disclose any decisions regarding the adjustment of the conversion price promptly following board meetings [9]